Mode
Text Size
Log in / Sign up

mRNA-1010

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of mRNA-1010

8 trials tracked of mRNA-1010: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 52 citations.

8Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 3 Phase 2 5
  1. Phase 3 Study of mRNA-1010 Seasonal Influenza Vaccine in Adults Completed · 52 cited
  2. Phase 3 A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults Completed
  3. Phase 3 A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older Completed
  4. Phase 2 A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old Completed
  5. Phase 2 A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults Completed
  6. Phase 2 A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults Completed
Show 2 more trials
  1. Phase 2 A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults Completed
  2. Phase 2 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.